There are currently 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Globus Medical stock.
Is GMED stock a good buy?
Zacks' proprietary data indicates that Globus Medical, Inc. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the GMED shares relative to the market in the next few months.
Who owns Globus Medical?
Type Public
------------ -------------------------------------------------------------------------------------------------
Founders David C. Paul
Headquarters Audubon, Pennsylvania, US
Key people David C. Paul (Chairman) David M. Demski (CEO) Daniel T. Scavilla (Senior Vice President and CFO)
Products Medical Devices